HYBRID ENDOVASCULAR REPAIR FOR THORACIC AORTIC DISEASE INVOLVING AORTIC ARCH  by Kim, Myeong Gun et al.
TCT@ACC-i2: Interventional Cardiology
A1755
JACC March 17, 2015
Volume 65, Issue 10S
hybrid endovasCUlar repair For thoraCiC aortiC disease involvinG aortiC arCh
Poster Contributions
Poster Hall B1
Saturday, March 14, 2015, 10:00 a.m.-10:45 a.m.
Session Title: Coronary I
Abstract Category: 31. TCT@ACC-i2: Carotid and Endovascular Intervention
Presentation Number: 2100-316
Authors: Myeong Gun Kim, Woong Chol Kang, Pyung Chun Oh, Eak Kyun Shin, Yae Min Park, Jeonggeun Moon, Wook-Jin Chung, 
Taehoon Ahn, Gil Medical Center, Gachon University, Incheon, South Korea
background:  To evaluate the outcomes of hybrid endovascular repair for thoracic aortic disease involving aortic arch
methods:  This study was a retrospective analysis involving patients who underwent hybrid endovascular repair for thoracic aortic disease 
involving aortic arch.
results:  Forty-five patients (35 men; mean age, 66.3±15.4 years) with thoracic aortic disease involving aortic arch were treated by 
hybrid endovascular repair. The indications for treatment included increased aneurysm size in 28 cases (52.2%), rupture or impending 
aneurysmal rupture in 10 cases (22.2%), rapid growth of aortic aneurysm (≥10 mm/y) in 5 cases (11.1%), pseudoaneurysm in 2 case 
(4.4%). Supra-aortic vessel transposition and stent-graft implantation were achieved in all cases. Three types of stent-graft were used, as 
follows: the Seal thoracic stent-graft in 15 patients (33.3%); the Valiant stent graft in 20 patients (44.4%); and the Zenith TX2 thoracic stent 
graft in 10 patients (22.2%). Perioperative complications affected 13 patients (28.8%), as follows: stroke (n=3, 6.7%); bleeding (n=1, 2.2%); 
renal failure (n=4, 8.9%); vascular injury (n=2, 4.4%); retrograde dissection (n=2, 4.4%); and respiratory failure (n=1, 2.2%). Two patients 
underwent reintervention in hospitalization due to increased size (n=1) and retrograde dissection (n=1). Four patients died within 30 days 
(8.9%) due to stroke (n=2); bleeding (n=1); and intracranial hemorrhage (n=1). Technical success was achieved in 21 patients (71.1%). 
Two patients died after discharge during follow-up (mean, 20.1±19.1 months) due to subdural hemorrhage (n=1); and end-stage renal 
disease (n=1). In 4 patients, reintervention was necessary due to persistent endoleaks (n=2); aortic rupture (n=1); and newly developed 
retrograde aortic dissection (n=1). The death-free survival and reintervention-free survival rates during follow-up were 82.4% and 76.3%, 
respectively.
Conclusion:  For thoracic aortic disease involving aortic arch, hybrid treatment with supra-aortic vessel transposition and endovascular 
repair may be an option in frail patients in who open procedures is too risky.
